Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05510908 · ClinicalTrials.gov registry record
Use of a Screening Tool to Describe HIV-Related Cancer Burden and Patient Characteristics in the AMC
A clinical trial, sponsored by AIDS Malignancy Consortium.
- Completed
- Registry status
- 460
- Enrollment target
NCT05510908: Completed study, sponsored by AIDS Malignancy Consortium.
NCT05510908 is a clinical trial that has completed, run by AIDS Malignancy Consortium. The registered enrollment target is 460 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05510908 has completed, sponsored by AIDS Malignancy Consortium.
- COMPLETED
- Registry status
- 460 participants
- Enrollment target
Study Summary
This study is being done to understand how many people with HIV (PWH) present for cancer care across the AIDS Malignancy Consortium in the United States and if there are reasons that some PWH choose to participate, or not in cancer clinical trials. Optional quality of life surveys will be used to learn more about how HIV and cancer and HIV and cancer treatment affect people.
Primary Outcome
For each cancer group listed below, the number of new and existing cases per month will be estimated. The distribution of cancer types will be computed as percentages and compared to the cancer type distribution in the HIV/AIDS Cancer Match (HACM) Study: 1. Solid organ tumors associated with human papillomavirus (HPV) infection 2. Solid organ tumors unrelated to HPV 3. Kaposi sarcoma 4. Hematologic malignancies
Interventions
- OTHER Non-Interventional
- OTHER Non-Interventional Follow-up
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 460 participants |
| Start Date | 2023-07-25 |
| Est. Completion | 2025-06-02 |
What the finished NCT05510908 record still lists
NCT05510908 is an observational study that tracks outcomes without assigning an intervention. The registered 460 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 2 interventions - of which Non-Interventional is the first listed.
NCT05510908 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05510908 about?
NCT05510908 is a clinical study titled "Use of a Screening Tool to Describe HIV-Related Cancer Burden and Patient Characteristics in the AMC". This study is being done to understand how many people with HIV (PWH) present for cancer care across the AIDS Malignancy Consortium in the United States and if there are reasons that some PWH choose to participate, or not in cancer clinical trials. Optional quality of life surveys will be used to le...
What is the current status of trial NCT05510908?
This trial is currently completed. The enrollment target is 460 participants. The study started on 2023-07-25. Estimated completion is 2025-06-02.
What interventions are being tested in trial NCT05510908?
The interventions under investigation include: Non-Interventional (OTHER), Non-Interventional Follow-up (OTHER).
Who is sponsoring clinical trial NCT05510908?
This trial is sponsored by AIDS Malignancy Consortium, which has 45 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02977780 · 460 participants · Phase 2
INdividualized Screening Trial of Innovative Glioblastoma Therapy (INSIGhT)
- NCT03427736 · 460 participants
Anesthetics and Analgesics in Children
- NCT03819933 · 460 participants · NA
Optimizing Family Counseling for Anticipated Extremely Preterm Delivery
- NCT04621279 · 460 participants
Cool Prime Comparative Effectiveness Study for Mild HIE
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI